Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

ReNeuron pleased to secure podium presentation for stroke data at US conference

Michael Hunt, CFO at ReNeuron Group Plc (LON:RENE) tells Proactive positive long-term data on their CTX cell therapy for stroke has been presented at the American Heart Association International Stroke Conference in Los Angeles.

Professor Keith Muir, of the Queen Elizabeth University Hospital, Glasgow and Principal Investigator for ReNeuron’s PISCES II study, told the audience that upper limb functional recovery was “durable and maintained” out to 12 months post-treatment.

 
Meet Grit Real Estate Income Group Ltd, Kogi Iron Ltd, Ethernity Networks Ltd and Advanced Blast & Ballistic Systems Ltd at our event, London , 15 November 2018. Register here »
View full RENE profile View Profile

ReNeuron Group Plc Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use